Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Feb;7(2):134-6.

What is the Role of Midodrine in Patients with Decompensated Cirrhosis?

Klara Werling  1 , Naga Chalasani
Affiliations

What is the Role of Midodrine in Patients with Decompensated Cirrhosis?

Klara Werling et al. Gastroenterol Hepatol (N Y). 2011 Feb.
No abstract available

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Kashani A, Landavere C, Medici V, Rossaro L. Fluid retention in cirrhosis: pathophysiology and management. QJM. 2008;101:71–85. - PubMed
    1. Gines P, Quintero E, Arroyo V, et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology. 1987;7:122–128. - PubMed
    1. Moreau R, Lebrec D. The use of vasoconstrictors in patients with cirrhosis: type 1 HRS and beyond. Hepatology. 2006;43:385–394. - PubMed
    1. Tandon P, Tsuyuki RT, Mitchell L, et al. The effect of 1 month of therapy with midodrine, octreotide-LAR and albumin in refractory ascites: a pilot study. Liver Int. 2009;29:169–174. - PubMed
    1. Kalambokis G, Fotopoulos A, Economou M, Pappas K, Tsianos EV. Effects of a 7-day treatment with midodrine in non-azotemic cirrhotic patients with and without ascites. J Hepatol. 2007;46:213–221. - PubMed

LinkOut - more resources